We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
(+59%)
Cap. Flow
+$36.7B
Cap. Flow
% of AUM
36.22%
Top 10 Holdings %
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
NVIDIA
NVDA
|
+$1.29B |
| 3 |
Apple
AAPL
|
+$690M |
| 4 |
Microsoft
MSFT
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.67B |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$204M |
| 3 |
SPDR Gold Trust
GLD
|
+$173M |
| 4 |
Costco
COST
|
+$161M |
| 5 |
Qualcomm
QCOM
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Financials | 3.61% |
| 4 | Healthcare | 3.25% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
Abeona Therapeutics
ABEO
$345M
| $67K | ﹤0.01% |
+12,028
| New | +$74K |
|
4777
Waldencast
WALD
$217M
| $66.7K | ﹤0.01% |
16,600
-78,847
| -83% | -$277K |
|
4778
Information Services Group
III
$185M
| $66.7K | ﹤0.01% |
19,969
+2,725
| +16% | +$9.11K |
|
4779
Enanta Pharmaceuticals
ENTA
$372M
| $66.5K | ﹤0.01% |
+11,558
| New | +$111K |
|
4780
CALL
Opendoor
OPEN
$3.69B
| $65.9K | ﹤0.01% |
+42,573
| New | +$77.1K |
|
|
TE
4781
T1 Energy
TE
$1.4B
| $65.7K | ﹤0.01% |
+25,484
| New | +$42.8K |
|
4782
Q32 Bio
QTTB
$450M
| $65.4K | ﹤0.01% |
+19,009
| New | +$600K |
|
|
NGD
4783
PUT
DELISTED
New Gold Inc
NGD
| $65.2K | ﹤0.01% |
+26,300
| New | +$72.6K |
|
4784
Gossamer Bio
GOSS
$66.5M
| $65.1K | ﹤0.01% |
71,944
-75,013
| -51% | -$64.3K |
|
4785
PUT
B2Gold
BTG
$5.16B
| $64.4K | ﹤0.01% |
+26,400
| New | +$77.5K |
|
4786
Aterian
ATER
$4.35M
| $64.2K | ﹤0.01% |
+26,770
| New | +$71.1K |
|
4787
CALL
Ocugen
OCGN
$410M
| $64.2K | ﹤0.01% |
+79,700
| New | +$73K |
|
4788
PUT
Amylyx Pharmaceuticals
AMLX
$2.05B
| $63.5K | ﹤0.01% |
+16,800
| New | +$79.1K |
|
4789
CALL
Hecla Mining
HL
$10.2B
| $63.3K | ﹤0.01% |
+12,900
| New | +$77.1K |
|
4790
Agilon Health
AGL
$1.64B
| $62.9K | ﹤0.01% |
+1,324
| New | +$80K |
|
4791
8x8 Inc
EGHT
$247M
| $62.6K | ﹤0.01% |
23,454
-99,056
| -81% | -$254K |
|
4792
United Maritime
USEA
$24.3M
| $62.3K | ﹤0.01% |
36,201
+18,117
| +100% | +$39.1K |
|
4793
Achieve Life Sciences
ACHV
$626M
| $61.7K | ﹤0.01% |
+17,519
| New | +$79.4K |
|
4794
PUT
Pacific Biosciences
PACB
$422M
| $60.4K | ﹤0.01% |
+33,000
| New | +$64.4K |
|
4795
PUT
RLX Technology
RLX
$2.48B
| $60.3K | ﹤0.01% |
+27,900
| New | +$50.2K |
|
4796
CALL
Stem
STEM
$49.2M
| $59.8K | ﹤0.01% |
+4,955
| New | +$42.7K |
|
4797
TScan Therapeutics
TCRX
$51.9M
| $59.2K | ﹤0.01% |
+19,461
| New | +$88.2K |
|
|
DMRA
4798
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.77B
| $59.1K | ﹤0.01% |
+12,701
| New | +$83.1K |
|
4799
Cenntro
CENN
$8.23M
| $59K | ﹤0.01% |
+918
| New | +$66.6K |
|
4800
PUT
Gevo
GEVO
$397M
| $58.7K | ﹤0.01% |
+28,100
| New | +$53.2K |
|
Similar funds
Squarepoint's Q4 2024 Portfolio in Review
As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.
- Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
- Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
- Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
- Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
- Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
- Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.
Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.